FDA to review "missing" drug company documents -- Lenzer 330 (7481): 7 -- BMJ
FDA to review "missing" drug company documents -- Lenzer 330 (7481): 7 -- BMJ
Eli Lilly & Prozac affaire.
The additional question is not just scientific, but moral: is it right to hidden documents and lack of transparency for secondary interest?
Eli Lilly & Prozac affaire.
The additional question is not just scientific, but moral: is it right to hidden documents and lack of transparency for secondary interest?
posted by Aloyzio Achutti at 4:02 PM
0 Comments:
Post a Comment
<< Home